Showing results (1-10 of 213) with videos related to
Sort By:
Pageof 22
Bulletin Du Cancer|September 28, 2020
[ALL in adult patients: Contribution and limits of pediatric management]Florence Rabian, Nicolas BoisselBest Practice & Research. Clinical Haematology|October 21, 2017
How should we treat the AYA patient with newly diagnosed ALL?Nicolas BoisselHematology. American Society of Hematology. Education Program|December 9, 2022
New developments in ALL in AYANicolas BoisselHematology. American Society of Hematology. Education Program|December 5, 2025
Where do immunotherapies stand in management of acute leukemia in adults?Nicolas BoisselCurrent Hematologic Malignancy Reports|November 25, 2019
Towards a Personalized Treatment of Patients with Chronic Myeloid LeukemiaFlorence Rabian, Etienne Lengline, Delphine ReaAnnals of Hematology|February 11, 2023
Benefits of dexamethasone on early outcomes in patients with acute myeloid leukemia with hyperleukocytosis: a propensity score matched analysisMarco Cerrano, Sylvie Chevret, Emmanuel Raffoux, et al.Plos One|July 7, 2022
Post-remission outcomes in AML patients with high hyperleukocytosis and inaugural life-threatening complicationsSofiane Fodil, Sylvie Chevret, Camille Rouzaud, et al.Blood|June 14, 2018
Acute lymphoblastic leukemia in adolescent and young adults: treat as adults or as children?Nicolas Boissel, André BaruchelBulletin Du Cancer|June 4, 2017
[Adolescents and young adults with acute lymphoblastic leukemia. A specific management]Nicolas Boissel, Stéphane DucassouPageof 22